Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles

Biomaterials

Volumn 31, Issue 27, 2010, Pages 7086-7095

  Zupke, O ^a   Distler, E ^a   Baumann, D ^b   Strand, D ^a   Meyer, R G ^a   Landfester, K ^b   Herr, W ^a   Mailander V ^a,b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MAX PLANCK INSTITUTE FOR POLYMER RESEARCH   (Germany)

Author keywords

Cell imaging; Cellular therapy; Dendritic cell; Nanoparticle

Indexed keywords

ANIMAL STUDIES; AUTOIMMUNE DISEASE; CELL IMAGING; CELL SURFACE MOLECULES; CELLULAR THERAPY; DENDRITIC CELL; DENDRITIC CELLS; ELISPOT; FLUORESCENCE INTENSITIES; FLUORESCENT NANOPARTICLES; FUNCTIONALIZED; FUNCTIONALIZED NANOPARTICLES; IMMUNE RESPONSE; MINIEMULSION PROCESS; NANOSIZED MATERIALS; PHYSIOLOGICAL FUNCTIONS; POLYMERIC NANOPARTICLES; T CELLS;

ANTIGENS; CELL MEMBRANES; DENDRIMERS; FLUORESCENCE; FUNCTIONAL POLYMERS; LABELING; POLYMERS; VIRUSES;

NANOPARTICLES;

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FLUORESCENT DYE; FLUOROCHROME; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; NANOPARTICLE; POLYMER; POLYSTYRENE; VIRUS ANTIGEN; POLYSTYRENE DERIVATIVE;

ANTIGEN PRESENTATION; ARTICLE; CELL FUNCTION; CELL LABELING; CELL MATURATION; CELL STIMULATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; EMULSION; ENZYME LINKED IMMUNOSPOT ASSAY; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, CONFOCAL; NANOPARTICLES; POLYSTYRENES;

ANIMALIA;

EID: 77954385642     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.05.073     Document Type: Article

References (35)

1. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007 Sep, 449(7161):419-426.
2. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007, 7(7):543-555.
3. Heath W.R., Belz G.T., Behrens G.M., Smith C.M., Forehan S.P., Parish I.A., et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 2004, 199:9-26.
4. Pinzon-Charry A., Maxwell T., Lopez J.A. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 2005, 83(5):451-461.
5. Tacken P.J., de Vries I.J., Torensma R., Figdor C.G. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007, 7(10):790-802.
6. Herr W., Ranieri E., Olson W., Zarour H., Gesualdo L., Storkus W.J. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses. Blood 2000, 96(5):1857-1864.
7. Mackensen A., Herbst B., Chen J.L., Kohler G., Noppen C., Herr W., et al. Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells. Int J Cancer 2000, 86(3):385-392.
8. Ranieri E., Herr W., Gambotto A., Olson W., Rowe D., Robbins P.D., et al. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J Virol 1999, 73(12):10416-10425.
9. Palucka K., Ueno H., Zurawski G., Fay J., Banchereau J. Building on dendritic cell subsets to improve cancer vaccines. Curr Opin Immunol 2010, 22(2):258-263.
10. Merad M., Hoffmann P., Ranheim E., Slaymaker S., Manz M.G., Lira S.A., et al. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med 2004, 10(5):510-517.
11. Beilhack A., Schulz S., Baker J., Beilhack G.F., Nishimura R., Baker E.M., et al. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 2008, 111(5):2919-2928.
12. Creusot R.J., Yaghoubi S.S., Chang P., Chia J., Contag C.H., Gambhir S.S., et al. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 2009, 113(26):6638-6647.
13. Baumjohann D., Lutz M.B. Non-invasive imaging of dendritic cell migration in vivo. Immunobiology 2006, 211(6-8):587-597.
14. Ishimoto H., Yanagihara K., Araki N., Mukae H., Sakamoto N., Izumikawa K., et al. Single-cell observation of phagocytosis by human blood dendritic cells. Jpn J Infect Dis 2008, 61(4):294-297.
15. Elamanchili P., Lutsiak C.M., Hamdy S., Diwan M., Samuel J. " Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. J Immunother 2007, 30(4):378-395.
16. Lim Y.T., Noh Y.W., Han J.H., Cai Q.Y., Yoon K.H., Chung B.H. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008, 4(10):1640-1645.
17. Noh Y.W., Lim Y.T., Chung B.H. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J 2008, 22(11):3908-3918.
18. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38(5):1404-1413.
19. Demento S.L., Eisenbarth S.C., Foellmer H.G., Platt C., Caplan M.J., Mark Saltzman W., et al. Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 2009, 27(23):3013-3021.
20. Cambi A., Lidke D.S., Arndt-Jovin D.J., Figdor C.G., Jovin T.M. Ligand-conjugated quantum dots monitor antigen uptake and processing by dendritic cells. Nano Lett 2007, 7(4):970-977.
21. Sen D., Deerinck T.J., Ellisman M.H., Parker I., Cahalan M.D. Quantum dots for tracking dendritic cells and priming an immune response in vitro and in vivo. PLoS One 2008, 3(9):e3290.
22. Landfester K. Miniemulsion polymerization and the structure of polymer and hybrid nanoparticles. Angew Chem Int Ed Engl 2009, 48(25):4488-4507.
23. Mailander V., Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 2009, 10(9):2379-2400.
24. Holzapfel V., Musyanovych A., Landfester K., Lorenz M.R., Mailander V. Preparation of fluorescent carboxyl and amino functionalized polystyrene particles by miniemulsion polymerization as markers for cells. Macromol Chem Phys 2005, 206(24):2440-2449.
25. Musyanovych A., Rossmanith R., Tontsch C., Landfester K. Effect of hydrophilic comonomer and surfactant type on the colloidal stability and size distribution of carboxyl- and amino-functionalized polystyrene particles prepared by miniemulsion polymerization. Langmuir 2007, 23(10):5367-5376.
26. Britten C.M., Meyer R.G., Kreer T.A., Drexler I., Wolfel T., Herr W. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J Immunol Methods 2002, 259(1-2):95-110.
27. Herr W., Linn B., Leister N., Wandel E., zumBuschenfelde K.H.M., Wolfel T. The use of computer-assisted video image analysis for the quantification of CD8(+) T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods 1997, 203(2):141-152.
28. Mailander V., Lorenz M.R., Holzapfel V., Musyanovych A., Fuchs K., Wiesneth M., et al. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 2008, 10(3):138-146.
29. Lorenz M.R., Holzapfel V., Musyanovych A., Nothelfer K., Walther P., Frank H., et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 2006, 27(14):2820-2828.
30. Fischer S., Uetz-von Allmen E., Waeckerle-Men Y., Groettrup M., Merkle H.P., Gander B. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials 2007, 28(6):994-1004.
31. Rejman J., Oberle V., Zuhorn I.S., Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377(Pt 1):159-169.
32. He C., Hu Y., Yin L., Tang C., Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010, 31(13):3657-3666.
33. Wang L., Nagesha D.K., Selvarasah S., Dokmeci M.R., Carrier R.L. Toxicity of CdSe nanoparticles in Caco-2 cell cultures. J Nanobiotechnology 2008, 6:11.
34. Elamanchili P., Diwan M., Cao M., Samuel J. Characterization of poly(d, l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 2004, 22(19):2406-2412.
35. de Vries I.J., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005, 23(11):1407-1413.